Search clinical trials for: fadraciclib

Total 4 results

Cyclacel Pharmaceuticals, Inc.

Active, not recruiting

Absorption, Metabolism, and Excretion of CYC065 in Healthy Male Subjects

Healthy

United States
Cyclacel Pharmaceuticals, Inc.

Recruiting

A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

Lymphoma | Solid Tumor, Adult

United States, Korea, Republic of, Spain
Cyclacel Pharmaceuticals, Inc.

Suspended

A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)

Leukemia | Myelodysplastic Syndrome(MDS)

United States
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Recruiting

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors (ESMART)

Pediatric Cancer

Italy, France, Denmark, Germany, Netherlands, Spain, United Kingdom

3

Subscribe